Debevoise & Plimpton advised Carlyle in the transaction. Carlyle (NASDAQ: CG) announced its strategic partnership with Orsini Specialty Pharmacy, the leading independent specialty pharmacy focused on rare...
Carlyle’s Partnership with Orsini and Consonance Capital Partners
Carlyle’s Investment in Resonetics
Debevoise & Plimpton has advised Carlyle on the deal, while Kirkland & Ellis has advised GTCR and its portfolio company Resonetics. Carlyle (NASDAQ: CG) executed its acquisition...
Medable’s $304 Million Series D Investment Round
Debevoise & Plimpton advised Blackstone Growth in the transaction while Gunderson Dettmer Stough Villeneuve Franklin & Hachigiam represented GSR Ventures and Tiger Global. Medable Inc., the...
Carlyle’s Investment in Saama
Sullivan & Cromwell advised Saama Technologies, Debevoise & Plimpton advised Carlyle, and Fenwick & West advised the syndicate on the deal. Carlyle (NASDAQ: CG) executed its...
Fort Dearborn’s Merger With Multi-Color Corporation
Kirkland & Ellis advised Fort Dearborn, Debevoise & Plimpton LLP advised CD&R on the transaction, while Latham & Watkins LLP represented Platinum Equity and Multi-Color Corporation....
Kelso & Company’s Acquisition of Ferraro Foods
Debevoise & Plimpton LLP advised Kelso & Company, while Winston & Strawn LLP served as legal counsel to Ferraro Foods in the transaction. Kelso & Company...
Insitro’s $400 Million Series C Financing Round
Debevoise & Plimpton LLP is advising Canada Pension Plan Investment Board (CPP Investments) as the lead investor in the transaction. insitro completed its $400 million Series C...